| dc.contributor | Universidade Estadual Paulista (Unesp) | |
| dc.date.accessioned | 2014-05-20T15:22:39Z | |
| dc.date.available | 2014-05-20T15:22:39Z | |
| dc.date.created | 2014-05-20T15:22:39Z | |
| dc.date.issued | 2002-09-05 | |
| dc.identifier | Journal of Pharmaceutical and Biomedical Analysis. Oxford: Pergamon-Elsevier B.V., v. 30, n. 2, p. 279-284, 2002. | |
| dc.identifier | 0731-7085 | |
| dc.identifier | http://hdl.handle.net/11449/33596 | |
| dc.identifier | 10.1016/S0731-7085(02)00339-4 | |
| dc.identifier | WOS:000178465900013 | |
| dc.identifier | 0072173018005712 | |
| dc.description.abstract | A versatile voltammetric method for quantitative determination of fenbendazole (FBZ) in commercial tablets has been proposed, where direct dissolution of tablets is carried out in 0.1 mol l(-1) tetrabutylamoniun tetrafluorborate containing dimethylformamide solutions. Linear sweep (LSV), square wave (SWV) and differential pulse (DPV) voltammetry techniques were applied to study FBZ at a glassy carbon electrode, exhibiting a well defined irreversible oxidation peak at 1.15 V vs. SCE. This methodology allows a precise quantitative determination of FBZ presenting detection limits of 5.2 x 10(-5) (LSV), 5.0 x 10(-6) (DPV) and 5.0 x 10(-5) mol l(-1) (SWV). (C) 2002 Elsevier B.V. B.V. All rights reserved. | |
| dc.language | eng | |
| dc.publisher | Elsevier B.V. | |
| dc.relation | Journal of Pharmaceutical and Biomedical Analysis | |
| dc.relation | 2.831 | |
| dc.relation | 0,919 | |
| dc.rights | Acesso restrito | |
| dc.source | Web of Science | |
| dc.subject | fenbendazole | |
| dc.subject | anthelmintic | |
| dc.subject | voltammetric determination | |
| dc.title | Voltammetric determination of fenbendazole in veterinarian formulations | |
| dc.type | Artículos de revistas | |
